Skip to search formSkip to main contentSkip to account menu

YM-231146

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

MorpholinesQuinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
YM-231146, a novel orally bioavailable inhibitor of vascular endothelial growth factor receptor-2, is effective against paclitaxel resistant tumors.
Chemotherapy using anticancer drugs induces serious the problem of multidrug resistance (MDR) in the cancer cells. In contrast… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)